BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rovira-Rigau M, Raimondi G, Marín MÁ, Gironella M, Alemany R, Fillat C. Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer. Mol Ther 2019;27:230-43. [PMID: 30341009 DOI: 10.1016/j.ymthe.2018.09.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liang Y, Tian WY, Huang JJ, Gao LX, Fan XH. MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells. Oncol Lett 2021;21:482. [PMID: 33968198 DOI: 10.3892/ol.2021.12743] [Reference Citation Analysis]
2 Kumar S, Behera A, Saha P, Kumar Srivastava A. The role of Krüppel-like factor 8 in cancer biology: Current research and its clinical relevance. Biochem Pharmacol 2021;183:114351. [PMID: 33253644 DOI: 10.1016/j.bcp.2020.114351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Brachtlova T, van Ginkel JW, Luinenburg MJ, de Menezes RX, Koppers-Lalic D, Pegtel DM, Dong W, de Gruijl TD, van Beusechem VW. Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format. Mol Ther Oncolytics 2020;19:332-43. [PMID: 33335978 DOI: 10.1016/j.omto.2020.10.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Raimondi G, Mato-Berciano A, Pascual-Sabater S, Rovira-Rigau M, Cuatrecasas M, Fondevila C, Sánchez-Cabús S, Begthel H, Boj SF, Clevers H, Fillat C. Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses. EBioMedicine 2020;56:102786. [PMID: 32460166 DOI: 10.1016/j.ebiom.2020.102786] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Chianese A, Santella B, Ambrosino A, Stelitano D, Rinaldi L, Galdiero M, Zannella C, Franci G. Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives. Cancers (Basel) 2021;13:2761. [PMID: 34199429 DOI: 10.3390/cancers13112761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Pascual-Sabater S, Raimondi G, Mato-Berciano A, Vaquero EC, Ausania F, Fillat C. Preclinical testing of oncolytic adenovirus sensitivity in patient-derived tumor organoids. STAR Protoc 2021;2:101017. [PMID: 34950892 DOI: 10.1016/j.xpro.2021.101017] [Reference Citation Analysis]
7 Wu TM, Liu JB, Liu Y, Shi Y, Li W, Wang GR, Ma YS, Fu D. Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control. Cancer Control 2020;27:1073274820934805. [PMID: 32806937 DOI: 10.1177/1073274820934805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Farrera-Sal M, Fillat C, Alemany R. Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses. Cancers (Basel) 2020;12:E1034. [PMID: 32340119 DOI: 10.3390/cancers12041034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
9 Luo W, Wang Y, Zhang T. Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer. Cancer Cell Int 2022;22:160. [PMID: 35443724 DOI: 10.1186/s12935-022-02583-1] [Reference Citation Analysis]
10 Kooshkaki O, Asghari A, Mahdavi R, Azarkar G, Parsamanesh N. Potential of MicroRNAs As Biomarkers and Therapeutic Targets in Respiratory Viruses: A Literature Review. DNA Cell Biol 2022;41:544-63. [PMID: 35699380 DOI: 10.1089/dna.2021.1101] [Reference Citation Analysis]
11 Raimondi G, Gea-Sorlí S, Otero-Mateo M, Fillat C. Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models. Cancers (Basel) 2021;13:3233. [PMID: 34203557 DOI: 10.3390/cancers13133233] [Reference Citation Analysis]
12 Wedge ME, Jennings VA, Crupi MJF, Poutou J, Jamieson T, Pelin A, Pugliese G, de Souza CT, Petryk J, Laight BJ, Boileau M, Taha Z, Alluqmani N, McKay HE, Pikor L, Khan ST, Azad T, Rezaei R, Austin B, He X, Mansfield D, Rose E, Brown EEF, Crawford N, Alkayyal A, Surendran A, Singaravelu R, Roy DG, Migneco G, McSweeney B, Cottee ML, Jacobus EJ, Keller BA, Yamaguchi TN, Boutros PC, Geoffrion M, Rayner KJ, Chatterjee A, Auer RC, Diallo JS, Gibbings D, tenOever BR, Melcher A, Bell JC, Ilkow CS. Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy. Nat Commun 2022;13:1898. [PMID: 35393414 DOI: 10.1038/s41467-022-29526-8] [Reference Citation Analysis]
13 Núñez-Manchón E, Farrera-Sal M, Otero-Mateo M, Castellano G, Moreno R, Medel D, Alemany R, Villanueva E, Fillat C. Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses. NAR Cancer 2021;3:zcab015. [PMID: 34316705 DOI: 10.1093/narcan/zcab015] [Reference Citation Analysis]
14 Aini S, Yan H, Ding W, Adi L, Su P. [Long-chain non-coding RNA MALAT1 regulates paclitaxel resistance of breast cancer cells by targeting miR-485-3p]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:698-702. [PMID: 32897218 DOI: 10.12122/j.issn.1673-4254.2020.05.13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Holbrook MC, Goad DW, Grdzelishvili VZ. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions. Cancers (Basel) 2021;13:1171. [PMID: 33803211 DOI: 10.3390/cancers13051171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hajeri PB, Sharma NS, Yamamoto M. Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity. Cancers (Basel) 2020;12:E1504. [PMID: 32526919 DOI: 10.3390/cancers12061504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Nisar M, Paracha RZ, Adil S, Qureshi SN, Janjua HA. An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer. Front Oncol 2022;12:875188. [PMID: 35686109 DOI: 10.3389/fonc.2022.875188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]